...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Biodegradable poly-l-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens
【24h】

Biodegradable poly-l-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens

机译:基于可生物降解的聚丙交酯的微粒作为丝状疫苗候选抗原的控释传递系统

获取原文
获取原文并翻译 | 示例

摘要

Modern recombinant vaccines are less immunogenic than conventional vaccines which require adjuvants to enhance the effect of a vaccine. Alum is being used as a standard adjuvant for protein based vaccines to augment immune response in several diseases. However, the problem associated with alum is it requires multiple closes at specific time intervals to achieve the adequate level of immunity. Currently the adjuvanticity of Poly-l-lactide microparticles as single dose immunization was explored to overcome multiple immunization and reported to be effective for several diseases. In this regard we adsorbed filarial recombinant chimeric multivalent vaccine candidates such as TV and FEP on to PLA by double emulsion method and analyzed the characterization of PLA encapsulated microparticles and evaluated its immune responses in mice. The efficacy of single dose of PLA encapsulated proteins was investigated in comparison with single dose of alum or protein alone. In mice, single dose of PLA encapsulated antigens such as TV and FEP elicited significantly high antibody titer of 50,000 and 64,000 respectively than single dose of alum adsorbed TV/FEP (6000/9000) and single dose of protein TV/PEP (3000/4000) alone. Further PLA encapsulated antigens induced higher levels of cellular proliferation together with significant (P < 0.0001) levels of cytokine response [PLA-TV induced high levels of IL-4 (Th2) and IFNI-gamma (Th1) cytokines whereas PLA-FEP showed high levels of IL-5(Th2) and IFN-gamma (Th1)] indicating a balanced response elicited by PLA antigens. Overall strong humoral and cellular responses were observed for PLA encapsulated antigens compared with single dose of alum adsorbed or protein alone. (C) 2014 Elsevier B.V. All rights reserved.
机译:现代重组疫苗的免疫原性低于传统疫苗,后者需要佐剂来增强疫苗的作用。明矾被用作基于蛋白质的疫苗的标准佐剂,以增强几种疾病的免疫反应。但是,与明矾有关的问题是,它需要在特定的时间间隔多次关闭才能获得足够的免疫力。目前,已经探索了聚-丙交酯微粒作为单剂量免疫的佐剂,以克服多重免疫,并且据报道对几种疾病有效。在这方面,我们通过双重乳剂法将丝状重组嵌合多价疫苗候选物(例如TV和FEP)吸附到PLA上,并分析了PLA包裹的微粒的表征并评估了其在小鼠中的免疫反应。与单剂量的明矾或单独的蛋白相比,研究了单剂量的PLA包封蛋白的功效。在小鼠中,单剂量的PLA封装的抗原(例如TV和FEP)分别引起的抗体滴度分别为50,000和64,000,分别明显高于明矾吸附的TV / FEP(6000/9000)和蛋白TV / PEP(3000/4000)。 )一个人。 PLA包裹的抗原进一步诱导了较高水平的细胞增殖以及显着(P <0.0001)水平的细胞因子反应[PLA-TV诱导了高水平的IL-4(Th2)和IFNI-γ(Th1)细胞因子,而PLA-FEP显示出高水平IL-5(Th2)和IFN-γ(Th1)的水平]表明PLA抗原引起的平衡反应。与单剂量的明矾吸附或单独的蛋白相比,PLA包埋的抗原总体上表现出强烈的体液和细胞反应。 (C)2014 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号